Christina Farr

Author of Second Opinion, a health-technology newsletter with more than 20,000 subscribers. Former journalist with CNBC, Fast company and Reuters, and VC with OMERS Ventures.

18 hours ago

Is health-tech entering its ‘influencer’ era?

And what are the pros and cons?

Christina Farr

Feb 21, 2025

4 questions on President Trump and IVF

I caught up with Conceivable Life Sciences’ Joshua Abram to understand the political landscape and its impact on reproductive health

Christina Farr

Feb 13, 2025

Care delivery in all 50 states? No longer as common as it used to be

Some digital health companies are getting more targeted with their approach

Christina Farr

Jan 30, 2025

There’s a new game in town for D2C health business models

And it’s rapidly evolving in real time!

Christina Farr

Jan 20, 2025

How are employers going to pay for cell and gene therapies?

Let’s get real about the alliance between U.S. health care and employment

Christina Farr

Jan 08, 2025

Why is healthcare so bad at cybersecurity?

Plus, some thoughts about Transcarent buying Accolade!

Christina Farr

Jan 02, 2025

The formula for a productive investor update email

Because so many of you asked for it!

Christina Farr

Dec 19, 2024

Some tips for raising money in 2025

Things have gotten a little better in digital health VC land, but it’s still challenging out there!

Leslie Schrock, +1

Dec 11, 2024

A letter to my kids about last week

How I’ve been thinking about recent events

Christina Farr

Dec 06, 2024

There’s about to be a lot of AI capital incineration

Health care VCs are flocking to AI - and it’s all starting to feel a lot like crypto

Christina Farr